ZIOPHARM Oncology

ZIOPHARM Oncology, Inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. We are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
Type
Public
HQ
Boston, US
Size (employees)
36 (est)+29%
ZIOPHARM Oncology is headquartered in Boston, US

Key People at ZIOPHARM Oncology

Jonathan Lewis

Jonathan Lewis

CEO
Caesar J. Belbel

Caesar J. Belbel

CLO

ZIOPHARM Oncology Office Locations

ZIOPHARM Oncology has office in Boston
Boston, US

ZIOPHARM Oncology Metrics

ZIOPHARM Oncology Summary

Market capitalization

$769.8 m

Closing share price

$6.2
ZIOPHARM Oncology's current market capitalization is $769.8 m.

ZIOPHARM Oncology Financials

ZIOPHARM Oncology's revenue is $800 k in FY, 2013 which is a 41.7% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$800 k$1.4 m

Revenue growth, %

71.6%

Operating expense total

$359.2 m$44.9 m$124.4 m

EBIT

($356.9 m)($43.5 m)($120.1 m)

Net Income

($340.8 m)($31.8 m)($120.1 m)

Operating cash flow

$68.2 m($25.4 m)$97.9 m

ZIOPHARM Oncology Market Value History

We estimate that ZIOPHARM Oncology's current employees are approximately 24% female and 76% male.

ZIOPHARM Oncology News

ZIOPHARM Oncology Company Life

You may also be interested in